Here are three things to know.
1. ProteiOS is a novel allograft-derived growth factor which provides several osteoinductive, angiogenic and mitogenic growth factors in a lyophilized powder form.
2. It can be used with any scaffold FDA-approved for use with bone marrow aspirate.
3. ProteiOS growth factor is Biologica’s first orthopedic and neurosurgery offering. The company launched ProteiOS in a targeted release in 2017 Q4; it is now available across the U.S.
More articles on biologics:
4 things to know about Datum Orthobiologics, a newly formed company
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
